TEIZA Initiates The Malaysian Blockchain Consortium with 19 Strategic Partners Through Historic MOU Signing Ceremony

TEIZA Initiates The Malaysian Blockchain Consortium with 19 Strategic Partners Through Historic MOU Signing Ceremony

KUALA LUMPUR, Malaysia, Nov. 26, 2025 /PRNewswire/ -- TEIZA, a blockchain company invested in by the Finran Group, announced the formation of the Malaysia Blockchain Consortium, marking a pivotal milestone in the nation's digital transformation...

Pin Therapeutics Initiates First-Patient Dosing of CK1α Degrader PIN-5018 in Phase 1 Trial

Pin Therapeutics Initiates First-Patient Dosing of CK1α Degrader PIN-5018 in Phase 1 Trial

Preclinical Results Demonstrate Complete Response and Tumor Regression in ACC PDX Models SEOUL, South Korea, Nov. 24, 2025 /PRNewswire/ -- Pin Therapeutics, a clinical-stage biotechnology company specializing in targeted protein degradation,...

LISCure Biosciences Initiates Global Phase 2 Trial of LB-P8 in Primary Sclerosing Cholangitis (PSC)

LISCure Biosciences Initiates Global Phase 2 Trial of LB-P8 in Primary Sclerosing Cholangitis (PSC)

SEOUL, South Korea, Nov. 10, 2025 /PRNewswire/ -- LISCure Biosciences ("LISCure"), a clinical-stage biopharmaceutical company, announced the initiation of patient dosing in a global Phase 2 clinical trial of LB-P8, a novel therapeutic candidate for...

LEPAS Elegant Technology, Defined by You: LEPAS Fun Test Drive Interprets a New Paradigm for Intelligent Driving via User Co-Creation

LEPAS Elegant Technology, Defined by You: LEPAS Fun Test Drive Interprets a New Paradigm for Intelligent Driving via User Co-Creation

WUHU, China, Oct. 24, 2025 /PRNewswire/ -- From October 18 to 19, the LEPAS Fun Test Drive event successfully took place, following the Global Journey of Elegant Driving (China Stop) that concluded on October 15. Together, the two events showcased...

Clover Initiates Phase I Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates

Clover Initiates Phase I Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates

-- Potential First-in-Class Respiratory Combination Vaccine Candidates SCB-1022 (RSV + hMPV) and SCB-1033 (RSV + hMPV + PIV3) Enter the Clinical Trial Stage -- SHANGHAI, June 17, 2025 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX:...

Quantum Metal Recovery Inc. Responds to Besra Gold's ASX Announcement, Initiates Legal Proceedings in Ontario

Quantum Metal Recovery Inc. Responds to Besra Gold's ASX Announcement, Initiates Legal Proceedings in Ontario

PENANG, Malaysia, June 6, 2025 /PRNewswire/ -- Quantum Metal Recovery Inc. (QMRI), the largest shareholder of Besra Gold Inc. (Besra), has issued a formal response to Besra's 22 May 2025 ASX announcement titled "Market Update: Clarification of...

menu
menu